Kent Lake Capital LLC Has $12.15 Million Stock Position in Veradigm Inc. (NASDAQ:MDRX)

Kent Lake Capital LLC raised its position in shares of Veradigm Inc. (NASDAQ:MDRXFree Report) by 12.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 925,000 shares of the software maker’s stock after purchasing an additional 104,049 shares during the period. Veradigm accounts for approximately 4.7% of Kent Lake Capital LLC’s holdings, making the stock its 2nd biggest position. Kent Lake Capital LLC owned approximately 0.85% of Veradigm worth $12,154,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Advisor Group Holdings Inc. lifted its stake in shares of Veradigm by 15.6% in the 4th quarter. Advisor Group Holdings Inc. now owns 4,833 shares of the software maker’s stock worth $85,000 after acquiring an additional 651 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Veradigm by 2.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 32,052 shares of the software maker’s stock worth $421,000 after acquiring an additional 836 shares during the period. Prelude Capital Management LLC lifted its stake in shares of Veradigm by 8.9% in the 3rd quarter. Prelude Capital Management LLC now owns 11,428 shares of the software maker’s stock worth $174,000 after acquiring an additional 930 shares during the period. Covestor Ltd lifted its stake in shares of Veradigm by 10.3% in the 3rd quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after acquiring an additional 966 shares during the period. Finally, Bank of Montreal Can lifted its stake in shares of Veradigm by 3.6% in the 1st quarter. Bank of Montreal Can now owns 34,210 shares of the software maker’s stock worth $768,000 after acquiring an additional 1,198 shares during the period.

Veradigm Stock Up 4.4 %

MDRX stock traded up $0.27 during midday trading on Monday, reaching $6.40. The company had a trading volume of 5,469,131 shares, compared to its average volume of 5,606,927. Veradigm Inc. has a 1 year low of $5.01 and a 1 year high of $14.99. The company has a 50 day moving average of $9.13 and a two-hundred day moving average of $11.37.

Analysts Set New Price Targets

MDRX has been the topic of a number of research reports. Royal Bank of Canada dropped their target price on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a report on Friday, January 19th. Stephens restated an “equal weight” rating and set a $13.00 price target on shares of Veradigm in a report on Tuesday, November 14th. Barclays began coverage on shares of Veradigm in a report on Wednesday, January 3rd. They set an “equal weight” rating and a $11.00 price target on the stock. Finally, StockNews.com began coverage on shares of Veradigm in a report on Tuesday, February 27th. They set a “hold” rating on the stock. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Veradigm currently has a consensus rating of “Hold” and a consensus price target of $13.25.

View Our Latest Research Report on Veradigm

Veradigm Profile

(Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

Institutional Ownership by Quarter for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.